Treatment for Multiple Sclerosis

January 18, 2017
Treatment for Multiple Sclerosis

Amanda Adcock presented "One Treatment Option for Multiple Sclerosis" at the Huntsville Multiple Sclerosis Awareness Group Meeting on 1-17-17. Here are highlights from her presentation:

Multiple Sclerosis is an Autoimmune Disease:

  • Multiple Sclerosis occurs when your immune cells attack healthy parts of your central nervous system
  • B & T immune cells are thought to
  • Multiple Sclerosis is thought to be triggered by a genetic predisposition AND environmental exposure
  • 50 different genes are associated with Multiple Sclerosis
Michael & Lane
Michael & Lane

If You Have MS, Be your own advocate

  • Is your current treatment for multiple sclerosis working?
  • Partner with your healthcare provider
  • Use diagnostic tests to judge your disease activity
  • Evaluate your personal preferences and goals for treatment
  • Does the schedule and delivery method of your treatment work with your lifestyle?
Greg & Olivia
Greg & Olivia


  • Is used to treat adults with relapsing MS
  • Is for people who have tried two or more MS medications and have not achieved desired results
  • Is thought to recognize and remove certain B & T immune cells thought to cause MS.
  • Is given in 5 consecutive days in an IV infusion. The IV infusion takes about 7 hours.
Beth & Norm
Beth & Norm

After treatment:

  • Your body slowly begins to replace the cells that were removed with new cells.
  • You will have a monthly blood draw to monitor your B & T immune cell levels.
  • 12 months after your first treatment, a second dose of IV infusion is given in 3 consecutive days.
  • Most people will not need to take any further treatments. Some people will need to take a third dose.
Amy & Tom
Amy & Tom


  • In a 2 year trial, people taking Lemtrada had 49% fewer relapse than people taking Rebif
  • People taking Lemtrada had 42% less disability progression as measured by the Expanded Disability Status Scale